Kikushige and colleagues found that Tim‐3 was highly expressed in AML stem progenitor cells, but not in normal HSCs, demonstrating that Tim‐3 could be used as a marker of LSCs.13 Here, HAVCR2 is linked to acute myeloid leukemia.